Commercial Value Realization for Pharma & Life Sciences.
New Title
The New Game Is Experiential Commerce. The New Standard Is Consumer-Grade.
Value Leakage Is the Challenge.
The System Is How You Get There.
Three Stages of Activation
Enterprise Activation Operationalizes the Discipline at the Pace, Depth and Scale the Stakes Actually Demands.
Most transformation efforts stall because the organization was never structurally equipped to operationalize the change it aspired to create. Customer Excellence Activation is designed to prevent that.
Schedule a Diagnostic Conversation →
REFRAME.
Strategic Reorientation to Build the Conviction Required to Act.
A change activation event, not a findings delivery. The Value Leakage Workbench runs your own commercial data, CRM, Rx trend, payer access, market share, through a purpose-built diagnostic that scopes and quantifies the problem before a single conversation happens in the field. That evidence goes into a room with the people who have portfolio authority. The stage closes when leadership has seen the value leakage that was always happening and cannot unsee it.
MOBILIZE.
Organizational Activation to Architect the Interventions that Move the Needle.
This is where the organization itself gets engaged at scale for the first time. Baseline field signals surface the nuanced, ground-level insight that the data alone couldn't show, and multi-disciplinary teams use it to design targeted interventions against the priority zones REFRAME quantified. The interventions are deployed to produce visible, felt impact, and the field signal and metrics they generate is the structural form and motions that everything after this phase is built on.
OPERATIONALIZE.
Deployment to Embed Value Realization Into Enterprise Ways of Working.
Baseline signals become a continuous listening system, and the workflows that identify and resolve barriers become how the organization runs. FieldOS, the featured Activation Pathway and tailored reference architecture for field intelligence and activation, is what this gets built on, instantiated inside ways of working. Other Modular Pathways are available where the commercial architecture calls for a different configuration. The stage is complete when the system is live and internally owned.
The Connective Tissue
The Native Artificial Intelligence
Advantage Driving Journey Progression.
Native within the VECTOR platform, AI connects the system, translating commercial data and human experience into real-time insight, analytics, and targeted intervention strategies that make value leakage visible, actionable, and addressable.
As a strategic partner, TheyDo serves as the shared AI-powered system of record and journey operations platform, aligning field, access, brand, medical, and omnichannel teams around a single progression reality, intervention workflow and impact measurement.
How the Work is Done
Motions That Build Momentum, Reduce Risk, Accelerate Speed-to-Value and
Make the Work Endure.
Employee-Owned Transformation
Change the organization co-designs and owns.
Built with leaders and teams from the first session, so the people who run it helped design it.
Player-Coach Model
Hands-on advisory, working on the inside.
I guide the work alongside leaders and teams so design and embedding stay connected.
DIagnostic Rigor
Every engagement begins with evidence.
Belief without measurement is conviction without direction. Every engagement is grounded in a diagnostic before a single solution is proposed.
AI Empowered
Every capability is AI native.
AI is not a future consideration. It is a native condition of every commercial capability we design and deploy.
Radical Co-Design
Non-negotiable cross-functional co-design.
Translating diagnostic findings into the operating logic, governance, workflows, and target-state architecture
Iterative Activation
Tightly scoped and time-bound sprints.
Deploy real-world proof of value and designed capabilities to maximize speed-to-value.
The Discipline
The Unifying Force Behind Value Realization for CMOs, Brand Marketers, Field Leaders, and CX Practitioners.
Customer Excellence Activation is not a theory. It is a proven, structural, and systemic approach to embedding customer-centricity into the core machinery of how organizations operate and how they create and deliver value. This is not about sitting adjacent to what already exists, it is about integrating the customer and their experience into the success formula of the enterprise.
The Signals
Core Strategic Challenges We Will Address Together Through Customer Excellence Activation.
Scientific and brand value is not fully translating into commercial and patient impact.
Breakthroughs and brand investment create the potential, but value leaks in the gaps between prescribing intent and real-world access, delivery, and adherence. That friction registers in the field as barriers long before it shows up in prescribing rates, adherence, or revenue.
Omnichannel, Digital and AI no longer create meaningful competitive differentiation.
With significant investments across the industry, these strategies have been democratized, and fail to produce lasting advantage on their own. Differentiation now comes from elevating experience alongside product and brand into a value proposition competitors cannot easily replicate.
Customer-centricity is treated as an aspiration, not built into the growth formula.
Most organizations declare the intent without the required leadership conviction or constructing the structural and systemic conditions to make it real. The result are capabilities that stay reactive and disconnected from the commercial engine, enough for performative reporting but not for impact.
Top 10 Global Pharma Case Example
Customer Excellence Activation Reignites Brand Growth Through Value Realization.
At a top 10 global pharma, a Customer Excellence Activation was executed across a therapeutic category with eight brands, included a Value Leakage Diagnostic and leadership immersion bootcamps that aligned C Suite, Brand, Field, Access, and CX leaders around a quantified post-script value realization gap at the brand and portfolio levels.
The work mapped $272M in commercial value leakage, with 9% lost between script written and filled, 14% lost between fulfillment and therapy initiation, and 11% lost during early drop off, producing five Cases for Change for priority brands and active development of an intervention portfolio design and deployment over a 30-60-90 day period.